Generation and Characterization of a Polyclonal Human Reference Antibody to Measure Anti-Drug Antibody Titers in Patients with Fabry Disease

Male patients with Fabry disease (FD) are at high risk for the formation of antibodies to recombinant α-galactosidase A (AGAL), used for enzyme replacement therapy. Due to the rapid disease progression, the identification of patients at risk is highly warranted. However, currently suitable reference...

Descripción completa

Detalles Bibliográficos
Autores principales: Lenders, Malte, Scharnetzki, David, Heidari, Ali, Di Iorio, Daniele, Wegner, Seraphine Valeska, Brand, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961705/
https://www.ncbi.nlm.nih.gov/pubmed/33800950
http://dx.doi.org/10.3390/ijms22052680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961705/
https://www.ncbi.nlm.nih.gov/pubmed/33800950
http://dx.doi.org/10.3390/ijms22052680

Ejemplares similares